伴小脑共济失调的抗N-甲基-D-天冬氨酸受体脑炎病例临床分析
Clinical analysis of anti-N-methyl-D-aspartate receptor encephalitis patients with cerebellar ataxia
查看参考文献17篇
|
文摘
|
目的分析总结合并小脑共济失调的抗N-甲基-D-天冬氨酸受体(NMDAR)脑炎患者的临床特点。方法回顾分析北京协和医院2011-2019年诊治的抗NMDAR脑炎患者中合并小脑共济失调患者的临床表现、实验室检查结果、治疗与预后。结果347例抗NMDAR脑炎患者中共有15例(4.3%)合并小脑共济失调,其中1例患者合并卵巢畸胎瘤,男性7例,女性8例,中位年龄28岁,从脑炎发病到出现小脑症状平均病程30.8 d,极期改良Rankin量表(mRS)评分平均3.73分,脑脊液白细胞中位数28×10~6/L。15例患者均接受了一线免疫治疗,1例患者接受了利妥昔单抗二线免疫治疗,9例患者接受了吗替麦考酚酯长程免疫治疗。随访时间7~66个月,末次mRS评分平均2.73分,预后良好者(mRS评分≤2分)6例(6/15)。结论抗NMDAR脑炎合并小脑共济失调者相对少见,此类患者在神经功能方面预后较差,应及时识别抗NMDAR脑炎患者的小脑共济失调症状,采用规范的免疫治疗方案和长程免疫治疗,以期改善预后。 |
|
其他语种文摘
|
Objective To analyze and summarize the clinical characteristics of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis patients with cerebellar ataxia. Methods The clinical manifestations, laboratory examinations, treatment and prognosis of anti-NMDAR encephalitis patients with cerebellar ataxia diagnosed and treated in Peking Union Medical College Hospital from 2011 to 2019 were retrospectively analyzed. Results About 4.3% (15 cases) of a total of 347 anti-NMDAR encephalitis patients were complicated with cerebellar ataxia, of which one patient had ovarian teratoma. There were seven male cases and eight female cases, with a median age of 28 years. The average duration from the onset of encephalitis to the onset of cerebellar symptoms was 30.8 days. The average modified Rankin Scale (mRS) score was 3.73. In the acute phase, the median cerebrospinal fluid leukocyte count was 28×10~6/L. All patients received first-line immunotherapy, of which one case additionally received second-line immunotherapy with rituximab and nine patients received long-term immunotherapy with mycophenolate mofetil. The follow-up time ranged from seven to 66 months. The average mRS score of the last time was 2.73, and only six patients (6/15) had good prognosis (mRS score≤2). Conclusions Patients with anti-NMDAR encephalitis and cerebellar ataxia are rare, and have relatively poor prognosis in terms of neurological function. Symptoms of cerebellar ataxia in anti-NMDAR encephalitis patients should be recognized in time, and standardized immunotherapy regimens and long-term immunotherapy should be adopted to improve the prognosis. |
|
来源
|
中华神经科杂志
,2021,54(6):574-578 【核心库】
|
|
DOI
|
10.3760/cma.j.cn113694-20200913-00703
|
|
关键词
|
脑炎
;
受体,N-甲基-D-天冬氨酸
;
小脑
;
共济失调
|
|
地址
|
1.
中国医学科学院北京协和医院神经科, 100730
2.
内蒙古自治区人民医院神经内科, 呼和浩特, 010017
3.
中国科学院心理研究所, 北京, 100101
|
|
语种
|
中文 |
|
文献类型
|
研究性论文 |
|
ISSN
|
1006-7876 |
|
学科
|
医药、卫生 |
|
基金
|
国家重点研发计划
|
|
文献收藏号
|
CSCD:6984623
|
参考文献 共
17
共1页
|
|
1.
中华医学会神经病学分会. 中国自身免疫性脑炎诊治专家共识.
中华神经科杂志,2017,50(2):91-98
|
CSCD被引
141
次
|
|
|
|
|
2.
王昕. 20例儿童抗N-甲基-D-门冬氨酸受体脑炎的前瞻性研究.
国际儿科学杂志,2016,43(7):581-584
|
CSCD被引
2
次
|
|
|
|
|
3.
Poorthuis M H F. Cerebellar ataxia as a presenting symptom in a patient with anti-NMDA receptor encephalitis.
Neurol Neuroimmunol Neuroinflamm,2019,6(4):e579
|
CSCD被引
2
次
|
|
|
|
|
4.
Xu X. Anti-NMDAR encephalitis: a single-center, longitudinal study in China.
Neurol Neuroimmunol Neuroinflamm,2019,7(1):e633
|
CSCD被引
9
次
|
|
|
|
|
5.
Wang B. Cerebellar ataxia as the initial symptom with lesions involving the cerebellum in patient with anti-NMDAR encephalitis: a rare case report and literature review.
J Neuroimmunol,2020,346:577293
|
CSCD被引
6
次
|
|
|
|
|
6.
Yeshokumar A K. Gait disturbance as the presenting symptom in young children with anti-NMDA receptor encephalitis.
Pediatrics,2016,138(3):e20160901
|
CSCD被引
1
次
|
|
|
|
|
7.
Iizuka T. Association of progressive cerebellar atrophy with long-term outcome in patients with anti-N-methyl-d-aspartate receptor encephalitis.
JAMA Neurol,2016,73(6):706-713
|
CSCD被引
10
次
|
|
|
|
|
8.
Levite M. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
J Neural Transm (Vienna),2014,121(8):1029-1075
|
CSCD被引
5
次
|
|
|
|
|
9.
Bliss T V. A synaptic model of memory: long-term potentiation in the hippocampus.
Nature,1993,361(6407):31-39
|
CSCD被引
220
次
|
|
|
|
|
10.
Lynch D R. N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents.
Mol Pharmacol,1994,45(3):540-545
|
CSCD被引
3
次
|
|
|
|
|
11.
Hughes E G. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis.
J Neurosci,2010,30(17):5866-5875
|
CSCD被引
38
次
|
|
|
|
|
12.
Perez C A. Overlapping autoimmune syndrome: a case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG)antibody disease.
J Neuroimmunol,2020,339:577124
|
CSCD被引
5
次
|
|
|
|
|
13.
沈东超.
抗N-甲基-D-天冬氨酸受体脑炎合并急性轴索型周围神经病一例. 2(1),2020:E042
|
CSCD被引
1
次
|
|
|
|
|
14.
殷旭华.
眼阵挛-肌阵挛综合征合并抗N-甲基-D-天冬氨酸受体脑炎一例. 2(1),2020:E057
|
CSCD被引
1
次
|
|
|
|
|
15.
Fan S. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
Mult Scler Relat Disord,2018,20:144-152
|
CSCD被引
25
次
|
|
|
|
|
16.
Nosadini M. Immune therapy in autoimmune encephalitis: a systematic review.
Expert Rev Neurother,2015,15(12):1391-1419
|
CSCD被引
28
次
|
|
|
|
|
17.
Peng Y. Validation of the NEOS score in Chinese patients with anti-NMDAR encephalitis.
Neurol Neuroimmunol Neuroinflamm,2020,7(5):e860
|
CSCD被引
4
次
|
|
|
|
|
了解气象卫星更多信息，请访问